ArticleClinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology2021

Dupilumab suppresses type 2 inflammatory biomarkers across multiple atopic, allergic diseases.

Jennifer D Hamilton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.